UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases.
Mineralys Therapeutics
3 followers
Slingshot Biosciences
3 followers
Kyverna Therapeutics
8 followers
Thermo Fisher Scientific
288 followers
Genentech
227 followers
Gilead Sciences
216 followers
Regeneron
186 followers
Biogen
168 followers
Agilent Technologies
102 followers
Neuralink
92 followers
BioMarin Pharmaceutical
60 followers
Alexion Pharmaceuticals
58 followers